Association of non-alcoholic fatty liver disease with renal stone disease detected on computed tomography  by Nam, In Chul et al.
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Objective:  To evaluate  the association  between  Non-alcoholic  fatty liver  disease  (NAFLD)  with  renal  stone
disease  detected  on computed  tomography  (CT).
Method:  A  total  1812  patients  who  underwent  abdomen-pelvis  CT in  July  2015  were  included  in this
study.  The  inclusion  criteria  for NAFLD  were  as  follows:  (i)  lower  average  Hounsﬁeld  unit  (HU)  of  hepatic
right  lobe,  left  medial  and  lateral  segment  when  compared  with  that  of  spleen,  (ii) patients  who  having
urolithiasis  in kidneys,  ureters  and  urinary  bladder,  and (iii)  patients  underwent  abdomen-pelvis  CT
including  noncontrast  image.  The  statistical  signiﬁcance  of  the association  between  NAFLD  and  renal
stone  disease  was assessed  using  Chi  Square  Test.  The  Odds  ratios  and  95%  CI were  calculated  to  assess
the  propensity  of  renal  stones  disease  for NAFLD  by  using  Logistic  Regression  analysis.
Results:  The  frequency  of renal  stone  disease  in  patients  with  NAFLD  was  higher  approximately  19% than
those  who  having  renal  stone  disease  without  NAFLD.  In  addition,  the  presence  of NAFLD  was  linked
with  renal  stone  disease  showing  that  detection  rate of renal  stone  disease  in  patients  with  NAFLD  was
markedly  high  (odds  ratio:  5, 95% CI, 3–8.2)  (p < 0.05)  in multivariate  analysis.
Conclusion:  The  presence  of  signiﬁcant  association  between  NAFLD  with  renal  stone  disease  and  NAFLD
may  be considered  to  be an  independent  variable  as  a risk  factor  for  renal  stone  disease.
©  2016  The  Author.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND. Introduction
Non-alcoholic fatty liver disease (NAFLD) has been recognized
s a liver manifestation of the metabolic syndrome [1]. The preva-
ence of NAFLD from United States, Europe and Asia is reported to be
p to third of the human population [2,3]. NAFLD is deﬁned as the
resence of at least 5% of the fat component in the liver without any
ther liver disease including alcohol related liver disease, chronic
iral hepatitis, use of medications resulting in hepatic steatosis such
s tamoxifen, herb medication or other chronic liver disease such as
utoimmune hepatitis. The guideline for NAFLD (endorsed as Amer-
can Association for the Study of Liver Disease, American College of
astroenterology and American Gastroenterological) deﬁnes sig-
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niﬁcant alcohol use as current or recent alcohol consumption more
than 21 drinks per a week in men  and 14 drinks per a week in
women [4]. NASH is a more progressive type of NAFLD and deﬁned
histologically by presence of hepatic cell injury with parenchymal
steatosis [4].
Recent studies concluded that NAFLD has no direct association
with renal function and mild renal function abnormality may  have
similar risk factors or disease process [5]. Renal stone disease is a
common renal disorder associated with crystal deposition in the
renal medulla and urinary tract. It is inﬂuenced by both intrin-
sic and extrinsic factors [6]. Recent epidemiological studies have
demonstrated that renal stone disease has an association with obe-
sity, diabetes mellitus, hypertension, and metabolic syndrome [7].
These results reveal that metabolic syndrome can result in changes
in process of urine concentration and dilution, causing an increased
risk of both uric acid and calcium oxalate stone formations [7]. In
the basis of these studies, renal stone disease may be related to
the metabolic syndrome and can be a component of the metabolic
syndrome.
Recently, we  noticed a concomitant diagnosis of both fatty liver
and renal stones disease in same patient on the basis of com-
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1
Total number and gender frequency of fatty liver and renal stone disease.
Gender Fatty liver Renal stone disease Number 2 (p)
Negative Positive
Male Negative 497 (92.2) 42 (7.8) 539 (100) 55.6
(p < 0.05)Positive 100 (69) 45 (31) 145 (100)
Female Negative 541 (91.5) 50 (8.5) 684 (100) 16.8
(p < 0.05)Positive 83 (78.3) 23 (21.7) 591 (100)
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Positive 183 (72.9) 
uted tomography (CT) ﬁnding in routine daily practice. Literature
eviews by using Pubmed articles demonstrate only two  recent
tudies were performed and revealed the association between fatty
iver and renal stone disease. Therefore, the purpose of our study
as to evaluate the prevalence of renal stone disease in the patients
ith NAFLD by using the CT examination.
. Material and methods
This prospectively collected and retrospectively evaluated study
as approved by the institutional review board, and informed con-
ent from patients was waived.
.1. Study population
From July 1, 2015 to July 31, 2015, a total of 1812 patients who
isited our institute with performed abdomen-pelvis CT initially
ligible. The inclusion criteria for NAFLD group were as follows: (i)
ower average Hounsﬁeld unit (HU) of hepatic right lobe, left medial
nd lateral segment when compared with that of spleen [8,9], (ii)
atients having radiopaque stones in the urinary tract including
idneys, ureters or urinary bladder, and (iii) patients underwent
bdomen-pelvis CT including noncontrast image. Control group
ere deﬁned as follows: (i) patients underwent abdomen-pelvis
T including noncontrast image, and (ii) patients whose HU of liver
arenchyma showed higher than that of spleen. Exclusion criteria
ere follows: (i) those who underwent abdomen-pelvis CT without
oncontrast image, (ii) those who had suboptimal image quality
f CT examination due to beam hardening artifact or respiration
rtifact, and (iii) those who having other liver disease including
iral hepatitis, liver cirrhosis, hepatocellular carcinoma, metastasis
rom other primary cancer, splenectomy status or abundant alcohol
onsumption.
Of the 1812 cases, 431 were excluded due to absence of noncon-
rast image (n = 257), viral hepatitis, liver cirrhosis or hepatocellular
arcinoma (n = 134), splenectomy status (n = 12), metastasis from
ther primary malignancy (n = 12), abundant alcohol consumption
n = 8) and suboptimal image quality (n = 8). Finally, 1381 cases
mean age: 55.8 years; range: 19–91 years; male:female = 684:697)
ere enrolled in this study. The case accrual process is summarized
n Fig. 1.
.2. CT protocols
A 128-detector row CT scanner (Deﬁnition AS+, Siemens
ealthcare, Forchheim, Germany) was used to perform the
bdomen-pelvis CT scan. All patients were in the supine position
nd were scanned from the lung base to the pubic symphysis. We
erformed a noncontrast scan. The scanning parameters were as
ollows: tube voltage, 120 kVp; collimation, 128 × 0.6 mm;  rotation
peed, 0.5 s; pitch, 0.8; reconstruction thickness, 3 or 5 mm;  and no
econstruction interval. Automatic exposure control (caredose 4D,
iemens Healthcare) was activated to decrease the radiation dose,92 (8.1) 1130 (100) 72
(p < 0.0568 (27.1) 251 (100)
however, automatic tube potential modulation (careKV, Siemens
Healthcare) was  not switched on. Sagittal and coronal reformatted
images were generated with a thickness of 3 mm.
2.3. Image analysis
All imaging analysis was performed by a fellowship-complete
academic radiologist with 3-year experience in reading abdomen-
pelvis CT who was  blinded to clinical and laboratory data. To obtain
HU of liver parenchyma and spleen, the radiologist derived average
HU value of liver parenchyma from three different hepatic seg-
ments including right hepatic lobe, left medial and lateral segment
by measuring region of interest in each segment. Fatty liver was
deﬁned when average HU of liver parenchyma lower than that
of spleen [8]. Then 4 weeks later, the radiologist reviewed elec-
tronic medical report of all enrolled patients to exclude those who
having other liver disease including viral hepatitis, liver cirrhosis,
hepatocellular carcinoma, metastasis from other primary cancer,
splenectomy status or abundant alcohol consumption (Fig. 2).
2.4. Statistical analysis
To assess the association between fatty liver and renal stone dis-
ease, the Chi Square test was used. The Odds ratios and 95% CI were
calculated to assess the propensity of renal stones disease for fatty
liver patients by using Logistic Regression analysis. A P value less
than 0.05 was  considered to indicate asigniﬁcant difference. The
statistical analysis was performed using Medcalc software for Win-
dow (Medcalc Software Version 11.3.8.0, Mariakerke, Belgium).
3. Results
Of the 1381 cases, 1038 were healthy group suggestive of no
fatty liver or renal stone disease (75% of total number). Fatty liver
were 251 patients (145 men, 106 women; mean age; 54.7 years; age
range, 19–90 years) and renal stone disease were 160 patients (87
men, 73 women; mean age, 54.9 years; age range, 20–86 years).
The frequency of renal stone disease in fatty liver patient group
was 27% (n = 68) (p < 0.05). In contrast, only 8% was noted as renal
stone disease in non-fatty liver patient group (n = 183) (p < 0.05)
(Table 1). The frequency of renal stone disease in male fatty liver
patient group was 31% (n = 45) and in female fatty liver patients
group was 21.7% (n = 23) (p = 0.208). Diagnosis of fatty liver demon-
strated an association with higher risk of developing renal stone
disease (odds ratio: 5, 95% CI, 3–8.2) (p < 0.05) (Table 2). The mean
and standard deviation of HU of liver was  51.9 ± 12 in patient with
renal stone disease and fatty liver and 56.4 ± 11 in patient with
renal stone disease without fatty liver, respectively (p < 0.05). The
frequency of fatty liver in renal stone disease (n = 160) was 42.5%
(n = 68), with the frequency of 54.4% and 45.6% in male and female,
respectively (p = 0.208). In contrast, the frequency of fatty liver in
patient without renal stone disease was 15%.
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Fig. 1. Flowchart of the case accrual process. Computed tomography (CT); Hepatocellular carcinoma (HCC); Non-alcoholic fatty liver disease (NAFLD). NAFLD was deﬁned as
fatty  liver showing lower Hounsﬁeld Unit than that of spleen on CT.
Fig. 2. Noncontrast scan images in a 55-year-old man  show diffuse fatty liver and right ureter stone on noncontrast image. He visited our hospitalwith acute right ﬂank pain,
and  his laboratory test revealed microscopic hematuria.
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Table 2
Multivariate risk factor analysis for renal stone disease.
Dependent variable Independent variable Odds ratio P value
Renal Gender 1.127 P = 0.491
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. Discussion
Our study showed that frequency of renal stone disease in
atient with NAFLD was higher approximately 19% than those who
aving renal stone disease without NAFLD. In addition, the pres-
nce of NAFLD was linked with renal stone disease showing that
etection frequency of renal stone disease in patients with NFALD
as markedly higher (odds ratio: 5, 95% CI, 3–8.2) (p < 0.05) in mul-
ivariate analysis. On the basis of these ﬁndings, we  suggested that
here’s signiﬁcant association between NAFLD with renal stone dis-
ase and NAFLD may  be considered to be an independent variable
s a risk factor for stone formation.
Our results correspond well with those of previous studies
10,11]. Einollahi et al. [10] investigated 11245 ultrasonography
eport in a cross sectional study. They found that the detection
ate of renal stone disease was 17% in patients with NAFLD and
% in patients without NAFLD, respectively. In addition, for NAFLD
atients, detection or diagnosis of fatty liver was associated with
 higher risk of developing renal stone disease (p < 0.0001), (odds
atio: 2.4, 95% CI 2.1–2.7). Even though the detection rate of renal
tone disease was signiﬁcantly higher in patients with NAFLD than
hat of patients without NAFLD in their study, however, it was
ower than that of our study. A discrepancy between our study and
heirs could be the difference of diagnostic performance between
ltrasonography and CT. Published sensitivity and speciﬁcities of
T routinely performed with slice collimations of less than 3 mm
pproach 98%–100% [12]. Also, a meta-analysis reported a sensitiv-
ty of 97% and a speciﬁcity of 95% for the detection of obstructive
reterolithiasis with CT [13]. However, Ray et al. [14] performed
 prospective evaluation of renal ultrasonography in the Emer-
ency Department followed by CT examination for the detection
f urolithiasis and they revealed that US performed poorly with
n accuracy of 67–77% and the limitation of US in clinical prac-
ice. Thus, we believe that it might be difﬁcult to properly evaluate
rolithiasis by using US resulting in relatively lower detection rate
f urolithiasis in patients. Paz et al. [11] retrospectively analyzed
 total of 100 patients who were indicated for renal colic and per-
ormed noncontrast CT images and they reported 37.5% NAFLD in
he positive urinary stone disease group as compared to 10% in the
on-urinary stone disease group with statistical signiﬁcance. Our
tudy revealed that detection rate of NAFLD was 42.6% in positive
enal stone disease and 15% in non-renal stone disease. Also, they
evealed that detection rate of urolithiasis was 93.8% in NAFLD and
3.5% in non-NAFLD, respectively. Although the detection rate of
enal stone disease was signiﬁcantly higher in patients with NAFLD
han that of patients without NAFLD in their study, however, detec-
ion rate of urolithiasis was  extremely higher than that of our study.
 discrepancy between our study and theirs could be the differ-
nce of inclusion criteria. All enrolled patients in their study were
linically suspected urolithiasis and it would lead to a selection bias.
It has well known that CT examination has a high sensitiv-
ty and speciﬁcity for detecting fatty liver and renal stone disease
12,13]. In addition, CT examination also can quantify liver fat accu-
ulation [8,15]. In our study, we reveal that the attenuation ofiver parenchyma in patients with renal stone disease signiﬁcantly
ower than that in patients without renal stone disease (p < 0.05).
owever, this disparity is too subtle to differentiate two  groups0.998 P = 0.71
1.01 P = 0.294
4.996 P < 0.05
for clinical physicians in visual assessment. Furthermore, HU was
no signiﬁcant association with renal stone disease in multivariate
analysis. Thus, we  suggest that the severity of fatty liver has no
association with renal stone disease.
The association between NAFLD and renal stone disease has
received little attention. In the review of recent literature, oxidative
and systemic metabolisms are compatible with stone formation
[16]. The kidneys is an highly vulnerable organ damaged by reac-
tive oxygen species, likely due to the abundance of long chain
poly unsaturated fatty acids in the composition of renal lipids and
systemic oxidative species can result in peroxidation of lipid that
may have an effect in calcium oxalate stone formation [16]. Fur-
ther data suggest that fatty liver may  result in changes in urinary
constituents, leading to an increased incidence of stone formation
[17].
The strong point of our study is that we  validated high relevance
between fatty liver with renal stone disease on the basis of CT ﬁnd-
ings that have a higher sensitivity and speciﬁcity to detect fatty liver
and renal stone disease than that of other imaging modality such
as ultrasonography which can miss the renal stone disease in daily
routine practice. Furthermore, it is noteworthy that the detection
rate of renal stone disease more increased in patients with NAFLD
(odds ratio: 5, 95% CI, 3–8.2) (p < 0.05) than that of other study.
There were several limitations to our study. First, the possibility
of selection bias should be considered because our results were
based on a retrospective study design. However, we attempted to
enroll all consecutive patients who met  the inclusion criteria during
the eligible period. Second, we  did not performed interobserver and
intraobserver reliability to evaluate NAFLD and renal stone disease.
In conclusion, the prevalence of renal stone disease in patients
with NAFLD was signiﬁcantly higher than that of patients with-
out NAFLD and the presence of NAFLD may be considered to be an
independent variable as a risk factor for renal stone disease.
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